Is SYRE stock safe? | Glauxie AI

Q: Is SYRE stock safe?

Spyre Therapeutics, Inc. (SYRE) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Cameron Turtle. Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human... Employees: 102.

Q: What are the risks of investing in SYRE?

Identify key risks of investing in SYRE — debt, competition, volatility, and sector headwinds.

Q: Is SYRE a good long-term investment?

Evaluate SYRE as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does SYRE have?

Review SYRE total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is SYRE stock safe?

🦉

Spyre Therapeutics, Inc. (SYRE)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOCameron Turtle

Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to the a4Ã7 integrin being developed for...

Key Executives

Name	Title
Brian Connolly	Chief Technical Officer
Cameron Turtle DPHIL	Chief Executive Officer & Director
Eric McIntyre	Vice President of Finance & Investor Relations
Heidy Abreu King-Jones	Chief Legal Officer & Corporate Secretary
James Myers	Vice President of Quality & Compliance
Janet Gunzner-Toste	Senior Vice President of Operations

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

SYRE Profile Financials

What are the risks of investing in SYRE? Is SYRE a good long-term investment? How much debt does SYRE have?